Daniel R. Passeri
Overview
Daniel R. Passeri received an average of $2M in total compensation, including $519K in salary, at Cue Biopharma from 2018 to 2023. Daniel Passeri also received an average of $986K at Curis from 2006 to 2008.
- 2023
- 2022
- 2020
- 2019
- 2018
- 2008
- 2007
- 2006
Cue BiopharmaChief Executive Officer
Cue BiopharmaChief Executive Officer
Cue BiopharmaChief Executive Officer
Cue BiopharmaChief Executive Officer
Cue BiopharmaChief Executive Officer
CurisChief Executive Officer
CurisChief Executive Officer
CurisChief Executive Officer
Source: SEC filings on April 26, 2024, April 26, 2021, May 29, 2020, April 17, 2009, and April 13, 2007.
Related executives
We found 11 more executives who work or worked at Cue Biopharma and Curis.
Anish Suri
Cue Biopharma
Chief Scientific Officer
Kerri-Ann Millar
Cue Biopharma
Chief Financial Officer
James Dentzer
Curis
Chief Executive Officer
William Steinkrauss
Curis
Chief Financial Officer
Robert Martell
Curis
Head of Research and Development
Colin Sandercock
Cue Biopharma
General Counsel
Michael Gray
Curis
Chief Financial Officer
Changgeng Qian
Curis